- Home
- AZI vs PBYI Comparison
AZI vs PBYI Comparison
Compare AZI & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- PBYI
- Stock Information
- Founded
- AZI 2010
- PBYI 2010
- Country
- AZI China
- PBYI United States
- Employees
- AZI N/A
- PBYI N/A
- Industry
- AZI
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- PBYI Health Care
- Exchange
- AZI Nasdaq
- PBYI Nasdaq
- Market Cap
- AZI 25.2M
- PBYI 171.7M
- IPO Year
- AZI 2024
- PBYI N/A
- Fundamental
- Price
- AZI $0.21
- PBYI $4.34
- Analyst Decision
- AZI
- PBYI Strong Buy
- Analyst Count
- AZI 0
- PBYI 1
- Target Price
- AZI N/A
- PBYI $7.00
- AVG Volume (30 Days)
- AZI 1.8M
- PBYI 543.3K
- Earning Date
- AZI 01-27-2025
- PBYI 11-06-2025
- Dividend Yield
- AZI N/A
- PBYI N/A
- EPS Growth
- AZI N/A
- PBYI 434.29
- EPS
- AZI N/A
- PBYI 0.97
- Revenue
- AZI $156,466,000.00
- PBYI $238,062,000.00
- Revenue This Year
- AZI N/A
- PBYI N/A
- Revenue Next Year
- AZI N/A
- PBYI N/A
- P/E Ratio
- AZI N/A
- PBYI $4.51
- Revenue Growth
- AZI 32.90
- PBYI 8.63
- 52 Week Low
- AZI $0.18
- PBYI $2.32
- 52 Week High
- AZI $3.20
- PBYI $6.07
- Technical
- Relative Strength Index (RSI)
- AZI 47.26
- PBYI 42.81
- Support Level
- AZI $0.19
- PBYI $4.49
- Resistance Level
- AZI $0.21
- PBYI $4.72
- Average True Range (ATR)
- AZI 0.01
- PBYI 0.26
- MACD
- AZI 0.00
- PBYI -0.12
- Stochastic Oscillator
- AZI 60.21
- PBYI 3.51
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.